Linked Data Explorerhttp://worldcat.org/entity/work/id/69767533
Therapeutic Strategies in Dementia
Widely acknowledged as one of the most challenging aspects of dealing with an ageing population, the increasing prevalence of cognitive decline in the elderly presents the clinician with a variety of complex therapeutic problems. Alzheimer's disease and other dementias vary in their onset and progression, as do patients in their responsiveness to treatment. Social management is as important as the choice of therapeutic agent, and implementing effective and sympathetic treatment requires care and sensitivity as well as a sound knowledge of currently available options. In this important new work.
Open All Close All
http://schema.org/about
- http://experiment.worldcat.org/entity/work/data/69767533#Topic/dementia_therapy
- http://experiment.worldcat.org/entity/work/data/69767533#Topic/dementia
- http://id.loc.gov/authorities/subjects/sh85004080
- http://experiment.worldcat.org/entity/work/data/69767533#Topic/demence_traitement
- http://experiment.worldcat.org/entity/work/data/69767533#Topic/central_nervous_system_agents_therapeutic_use
- http://experiment.worldcat.org/entity/work/data/69767533#Topic/health_&_fitness_diseases_alzheimer_s_&_dementia
- http://experiment.worldcat.org/entity/work/data/69767533#Topic/central_nervous_system_agents
- http://id.worldcat.org/fast/890070
- http://experiment.worldcat.org/entity/work/data/69767533#Topic/alzheimer_disease_drug_therapy
- http://experiment.worldcat.org/entity/work/data/69767533#Topic/alzheimer_disease
- http://id.loc.gov/authorities/subjects/sh2009123113
- http://id.worldcat.org/fast/806591
- http://experiment.worldcat.org/entity/work/data/69767533#Topic/alzheimer_s_disease
- http://experiment.worldcat.org/entity/work/data/69767533#Topic/alzheimer_maladie_d_traitement
- http://experiment.worldcat.org/entity/work/data/69767533#Topic/medical_neurology
- http://experiment.worldcat.org/entity/work/data/69767533#Topic/electronic_books
http://schema.org/description
- "Widely acknowledged as one of the most challenging aspects of dealing with an ageing population, the increasing prevalence of cognitive decline in the elderly presents the clinician with a variety of complex therapeutic problems. Alzheimer's disease and other dementias vary in their onset and progression, as do patients in their responsiveness to treatment. Social management is as important as the choice of therapeutic agent, and implementing effective and sympathetic treatment requires care and sensitivity as well as a sound knowledge of currently available options. In this important new work."@en
- "Widely acknowledged as one of the most challenging aspects of dealing with an ageing population, the increasing prevalence of cognitive decline in the elderly presents the clinician with a variety of complex therapeutic problems. Alzheimer's disease and other dementias vary in their onset and progression, as do patients in their responsiveness to treatment. Social management is as important as the choice of therapeutic agent, and implementing effective and sympathetic treatment requires care and sensitivity as well as a sound knowledge of currently available options. In this important new work, leading experts review the therapeutic agents currently available and assess their effectiveness. Also included is an update on recent and on-going clinical trials, the prospects for new therapeutic targets and the development of new biomarkers that will aid recognition of disease and earlier intervention."@en
- "Widely acknowledged as one of the most challenging aspects of dealing with an aging population, the increasing prevalence of cognitive decline in the elderly presents the clinician with a variety of complex therapeutic problems. Alzheimer's disease and other dementias vary in their onset and progression, as do patients in their responsiveness to treatment. In this book, leading experts review the current and evolving therapeutic options, including anti-amyloid therapies, neuroprotective strategies, and symptomatic treatments (both pharmacological and non-pharmacological). Also included are updates on several recent and on-going clinical trials, the development of new biomarkers to aid recognition of disease and earlier intervention, and a discussion of the pharmacoeconomics of treating dementia."
http://schema.org/genre
- "Electronic books"@en